Rajinder Suri

DCVMN

Rajinder Suri has over 40 years of experience in pharmaceuticals and biologics in India and international markets. He was a member of the Board of Directors of the Indian subsidiary of Sanofi Pasteur and held the position of CEO of Panacea Biotec.

He is currently the CEO of the Developing Countries Vaccine Manufacturers Network (DCVMN).

The 8th International Symposium on Immunobiologicals is organized by the Institute of Technology in Immunobiologicals, Bio-Manguinhos / Fiocruz. The partial reproduction of this site is permitted, once the source is mentioned. The use of images is allowed, as long as it complies with the Creative Commons standards mentioned in the credits.

Privacy policy

O 8th International Symposium on Immunobiologicals é organizado pelo Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos/Fiocruz. Permitida reprodução parcial deste site, desde que citada a fonte. O uso das imagens é permitido, desde que cumpra as normas Creative Commons citadas nos créditos.

Política de Privacidade

Avenida Brasil, 4.365, Pavilhão Rocha Lima, Manguinhos Rio de Janeiro – RJ - CEP: 21040-900

Rajinder Suri

Rajinder Suri

Share